Buys
Open market- Shares
- Avg price
- Total value
Jill Marie Broadfoot - Chief Financial Officer at aTYR PHARMA INC
Issuer-level insider activity
- Role
- Chief Financial Officer
- Issuer ticker
- ATYR on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Jill Marie Broadfoot in aTYR PHARMA INC
Sells
Open market- Shares
- -1,558
- Avg price
- $0.9760
- Total value
- -$1,521
Net
Past year- Shares
- -1,558
- Share %
- -100%
- Total value
- -$1,521
Reported holdings for Jill Marie Broadfoot in aTYR PHARMA INC
Form 4 holding
Chief Financial Officer
aTYR PHARMA INC
- Security class
- Common Stock
- Shares / value
- 37,296
- Estimated value
- $36,400
- Report date
- 04 Feb 2026
- Price
- $0.9760
- Ownership
- Direct
Form 4 holding
Chief Financial Officer
aTYR PHARMA INC
- Security class
- Restricted Stock Unit
- Shares / value
- 0
- Estimated value
- $14,175
- Report date
- 03 Feb 2026
- Price
- $3.78
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Chief Financial Officer
aTYR PHARMA INC
- Security class
- Employee Stock Option (right to buy)
- Shares / value
- 412,500
- Estimated value
- Report date
- 09 Jan 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Jill Marie Broadfoot in aTYR PHARMA INC
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.